Select a Meeting...
- SHM Converge 2025
- SHM Converge 2024
- SHM Converge 2023
- SHM Converge 2022
- SHM Converge 2021
- Hospital Medicine 2020, Virtual Competition
- Hospital Medicine 2019, March 24-27, National Harbor, Md.
- Hospital Medicine 2018; April 8-11; Orlando, Fla.
- Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
- Hospital Medicine 2016, March 6-9, San Diego, Calif.
- Hospital Medicine 2015, March 29-April 1, National Harbor, Md.
- Hospital Medicine 2014, March 24-27, Las Vegas, Nev.
- Hospital Medicine 2013, May 16-19, National Harbor, Md.
- Hospital Medicine 2012, April 1-4, San Diego, Calif.
- Hospital Medicine 2011, May 10-13, Dallas, Texas.
- Hospital Medicine 2010, April 8-11, Washington, D.C.
- Hospital Medicine 2009, May 14-17, Chicago, Ill.
- Hospital Medicine 2008, April 3-5, San Diego, Calif.
- Hospital Medicine 2007, May 23-25, Dallas, Texas
- Hospital Medicine 2006, May 3-5, Washington, D.C.
Meetings Archive For SHM Converge 2025..
Abstract Number: 0128
SHM Converge 2025
Background: The hospitalist system in Korea was introduced to address gaps in inpatient care and enhance safety. Despite increasing demand, research on the impact of hospitalists’ years of experience on care quality remains limited. Methods: A retrospective cohort study was conducted in multiple tertiary centers with inpatient internal medicine hospitalist wards. Hospitalists who began working [...]
Abstract Number: 0130
SHM Converge 2025
Background: In the United States (US), obesity is associated with a high burden of morbidity and mortality, and its prevalence is increasing. A higher prevalence of obesity disproportionately impacts rural (vs. urban) areas and the Midwest and South (vs. West and Northeast) regions (1-2). In addition, obesity is linked with greater healthcare costs compared to [...]
Abstract Number: 0131
SHM Converge 2025
Background: There are approximately 500,000 episodes of alcohol withdrawal that require pharmacologic treatment yearly. Lorazepam is commonly used due to its high therapeutic to-toxic effect index and its status as historically being the usual treatment. Phenobarbital is another common drug used to treat alcohol withdrawal. Patients with heavy alcohol use may become resistant to some [...]
Abstract Number: 0132
SHM Converge 2025
Background: Urgency of and time to antibiotic administration has often been highlighted to prevent complications of community acquired pneumonia (CAP). Adult literature is mixed on whether administration of antibiotics within four hours of diagnosis of CAP reduces morbidity and mortality, however this has not been studied in pediatric patients. We evaluated whether time to antibiotics [...]
Abstract Number: 0133
SHM Converge 2025
Background: Patients with opioid use disorder (OUD) are frequently hospitalized, however up to 25% of these encounters end in patient directed discharge (PDD), leading to interruptions in care, increased mortality, and higher hospital readmission rates.1-4 Receipt of medications for opioid use disorder (MOUD) has been shown to decrease odds of PDD.5 However, to date, less [...]
Abstract Number: 0134
SHM Converge 2025
Background: Ischemic heart disease (IHD) is a leading cause of mortality globally and in the United States which necessitates an understanding of long-term trends to inform interventions. IHD encompasses various conditions such as coronary artery disease and heart attacks, contributing significantly to the global burden of cardiovascular diseases. The high prevalence of risk factors, including [...]
Abstract Number: 0135
SHM Converge 2025
Background: Patients with acute severe asthma exacerbations that are unresponsive to standard therapy are said to be in status asthmaticus (SA). Patients with SA need hospitalization and are at risk of considerable morbidity and mortality along with high healthcare costs. Understanding regional differences in clinical outcomes and healthcare utilization among patients hospitalized with SA may [...]
Abstract Number: 0136
SHM Converge 2025
Background: Tobacco use remains a major public health issue in the United States as it is linked to a broad spectrum of serious diseases. Although intensive inpatient tobacco treatment programs have shown success, the impact of prescription of smoking cessation medications alone on hospital readmissions has not been thoroughly studied. This study aims to assess [...]
Abstract Number: 0137
SHM Converge 2025
Background: Metabolic dysfunction-associated steatotic liver disease (MALSD) is a recent classification that better reflects the cardiometabolic factors contributing to the condition, while reducing stigma associated with previous terminology. Characterized by triglyceride accumulation, MALSD can progress to inflammation and fibrosis if untreated. Although the FIB-4 score is commonly used to assess liver fibrosis, its association with [...]
Abstract Number: 0138
SHM Converge 2025
Background: Sepsis is a leading cause of morbidity and mortality among hospitalized patients. Previous studies have demonstrated that rates of sepsis and its complications – including organ failure, readmission, and death – are higher among Black patients than white patients (1, 2). While some of these differences can be explained by socioeconomic inequities, comorbidities, and [...]